Spago Nanomedical AB (SPAGO) Stock Price & Analysis

1 Followers

SPAGO Stock Chart & Stats

kr 0.03-kr 0.00(-2.94%)

At close: Nov 03 5:30 PM GMT+1

Day’s Range: SEK 0.03 - SEK 0.04
52-Week Range: SEK 0.03 - SEK 0.21
Previous Close: SEK 0.03
Volume: N/A
Average Volume (3M): 1.71M
Market Cap: SEK 27.46M
Enterprise Value: SEK 44.74M
Total Cash (Recent Filing): SEK 32.51M
Total Debt (Recent Filing): SEK 0
Price to Earnings (P/E): ―
Beta: 1.21
Next Earnings: Nov 05, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Zero Debt

A debt-free balance sheet reduces interest burden, refinancing exposure, and the risk that lenders constrain strategic choices. This gives Spago greater flexibility to direct available capital toward advancing its oncology nanomedicine pipeline, even though losses remain substantial.

Losses Narrowing

The narrowing of annual losses suggests some progress in controlling the cost base relative to earlier periods. If this trend continues alongside clinical and commercial development, it could extend financial runway and improve the company’s ability to scale its platform over time.

Improving Cash Outflows

Lower cash outflows than in 2023–2025 indicate a directionally better funding profile, even though the company is still not self-funding. Sustained improvement would slow capital depletion and provide more time to advance products before additional financing is required.

Bears Say

Minimal Declining Revenue

Extremely low and sharply declining revenue demonstrates that Spago has not yet established meaningful commercial scale. This limits internally generated funding, leaves the cost base far above current sales, and makes future progress dependent on successful development and commercialization.

Persistent Cash Burn

Persistent negative operating and free cash flow means the business cannot currently finance its activities from operations. Continued cash burn increases reliance on external funding, while unfavorable financing conditions or delays in development could restrict investment in the pipeline.

Shrinking Equity Cushion

The substantial reduction in equity reflects sustained losses and has materially reduced the company’s financial cushion. A smaller capital base leaves less capacity to absorb continued development costs and increases the importance of future operating improvement or additional funding.

SPAGO FAQ

What was Spago Nanomedical AB’s price range in the past 12 months?

Spago Nanomedical AB lowest stock price was kr 0.03 and its highest was kr 0.21 in the past 12 months.

What is Spago Nanomedical AB’s market cap?

Spago Nanomedical AB’s market cap is kr 27.46M.

When is Spago Nanomedical AB’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Spago Nanomedical AB’s earnings last quarter?

Spago Nanomedical AB released its earnings results on Aug 20, 2026. The company reported -kr 0.011 earnings per share for the quarter.

Is Spago Nanomedical AB overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Spago Nanomedical AB pay dividends?

Spago Nanomedical AB does not currently pay dividends.

What is Spago Nanomedical AB’s EPS estimate?

Spago Nanomedical AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Spago Nanomedical AB have?

Spago Nanomedical AB has 798,380,100 shares outstanding.

What happened to Spago Nanomedical AB’s price movement after its last earnings report?

Spago Nanomedical AB reported an EPS of -kr 0.011 in its last earnings report. Following the earnings report the stock price went up 3.448%.

Which hedge fund is a major shareholder of Spago Nanomedical AB?

Currently, no hedge funds are holding shares in SE:SPAGO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description